Talking With Your Doctor
Tools and Resources
Important Risk Information
Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children,
teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases
in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored
appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. VIIBRYD is
not approved for use in patients under 18. For more information on this risk, please read the VIIBRYD Medication
Guide in the accompanying full Prescribing Information.
These are not all the possible side effects of VIIBRYD. For more information, ask your healthcare
provider or pharmacist.
Call your doctor for medical advice about side effects.
Please also see Medication Guide within
You are now leaving Viibryd.com
Please note: Forest Laboratories, Inc. is not responsible for the content or services on the site you will now visit.
The information contained in this website is intended for healthcare professionals in the United States.
I certify that I am a healthcare professional in the United States.